Read + Share
Gounder MM, Bauer TM, Schwartz GK, Weise AM, et al. A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients
With Advanced Liposarcoma, Solid Tumors, or Lymphomas. J Clin Oncol 2023;41:1714-1724.
PMID: 36669146
|
 |
|
Gounder MM, Bauer TM, Schwartz GK, Weise AM, et al. A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients
With Advanced Liposarcoma, Solid Tumors, or Lymphomas. J Clin Oncol 2023;41:1714-1724.
PMID: 36669146
|
|
|
|